DOR BioPharma Announces Named Patient Access Program for Latin America in Collaborati

[NewsWhore]

DORB ) ("DOR" or the "Company"), a late-stage biopharmaceutical company developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases, an...

More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/17643334/)